March 28, 2019 Medical Grand Rounds Recap
The 9th Annual Global Health Day Medical Grand Rounds, “Strategies for Academic Global Engagement: Lessons from the Field,” was presented by Sten H. Vermund, MD, PhD, dean and Anna M.R. Lauder Professor of Public Health, Yale School of Public Health and professor of pediatrics, Yale School of Medicine (YSM).
Friedland Honored for Career’s Work in South Africa
Gerald Friedland, MD, professor emeritus and senior research scientist in medicine (infectious diseases) and professor emeritus of medicine, epidemiology and public health; was recently honored at a ceremony at the HIV clinic in Tugela Ferry, KwaZulu-Natal province, South Africa.
Bonds of MUYU Partnership Strengthened During Makerere University Visit
Pericles Lewis, vice president for global strategy and deputy provost for international affairs, visited Makerere University in Kampala, Uganda (MUK) on March 13 to meet with university leaders, alumni, and medical residents, as well as the leadership of the Makerere University-Yale University (MUYU) collaboration. Under the partnership, Yale physicians, residents, and medical students travel to Kampala for clinical rotations, and Ugandan physicians and students train in New Haven. The goal for both groups is to improve patient care through education, training, and research; to build up the educational and clinical infrastructure; and to support research that could be easily translated into practice.
After Ebola crisis, Yale works to strengthen Liberian health system
In 2014, the West African countries of Liberia, Guinea, and Sierra Leone suffered the most severe outbreak of Ebola ever known. By the time the epidemic was contained in 2016, the Center for Disease Control (CDC) estimates there were nearly 29,000 cases resulting in more than 11,000 deaths.
USC study links PFAS to liver damage; YSPH scientist contributed to research
YSPH scientist Vasilis Vasiliou, Ph.D., department chair and Susan Bliss Professor of Epidemiology (Environmental Health Sciences), contributed to a new study by the University of Southern California’s Keck School of Medicine linking chemicals known as PFAS to liver damage.
Award-winning journalist discusses lessons learned during COVID-19 pandemic
Pulitzer-winning science journalist and 2022 Yale Poynter Fellow Ed Yong talked April 7 to an audience at the Yale Law School about lessons learned from the COVID-19 pandemic. The event, Normal Led to This: On Two Years of Covering the Pandemic, was a methodological recounting of how the United States botched its response to COVID-19.
YSPH-led Study Identifies Drug-Resistant Tuberculosis Strains Spreading in Moldova
Public health experts are getting a better picture of drug-resistant tuberculosis in Moldova, thanks to the efforts of a coalition of researchers from across the world led by scientists at the Yale School of Public Health.
IOM and Yale School of Public Health Launch Data Responsibility Initiative
The International Organization for Migration (IOM) and Yale School of Public Health (YSPH) are collaborating to produce a series of articles capturing best ethical, technical, and contextual data responsibility practices across the public health sectors in humanitarian response, human development, and migration management.
Yale Center for Methods in Implementation and Prevention Science Faculty Member Dr. Ashley Hagaman Receives NIH Award for Implementation Research in Pakistan
Depression and suicide ideation remain leading causes of death among women of reproductive age worldwide. Despite this growing issue, many countries do not have adequate resources to address and improve mental health. In Pakistan, where Dr. Ashley Hagaman collaborates with her research partners, peer mothers have connected with mothers in the community to provide them with treatment and care for depression.
Experts question unusual authorization plan for Covid vaccine for kids under 5
The Food and Drug Administration’s willingness to consider authorizing a Covid-19 vaccine developed by Pfizer and BioNTech for children under the age of 5 — without evidence yet that it would be protective — is raising concerns among some vaccine experts who fear the plan could backfire and undermine vaccine uptake in this group.Source: Stat